Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4105907 Target Snapshot

Sigma intracellular receptor 2 · SINGLE PROTEIN · Homo sapiens

1,197Compounds
186Assays
32Approved Drugs
1,316.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q5BJF2. Use UniProt Q5BJF2 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q5BJF2 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sigma intracellular receptor 2 as ChEMBL target CHEMBL4105907, mapped to UniProt Q5BJF2. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sigma intracellular receptor 2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4105907
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q5BJF2
Sigma intracellular receptor 2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sigma intracellular receptor 2 is the right protein anchor across sources, using UniProt Q5BJF2 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSigma intracellular receptor 2
UniProt AccessionQ5BJF2
Component TypeProtein
Sequence Length176 aa

Sigma intracellular receptor 2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sigma intracellular receptor 2, mapped to UniProt Q5BJF2. Sequence length is 176 aa.

Mapped IDQ5BJF2
Review nameSigma intracellular receptor 2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

32
Approved
2
Phase III
13
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5025.0
KI1,284.0
KD7.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL61479 9.92 Ki 0.12 Clinical
CHEMBL227126 9.59 Ki 0.26 Preclinical
CHEMBL53325 9.47 Ki 0.34 Preclinical
CHEMBL5426155 9.37 Ki 0.43 Preclinical
CHEMBL4853196 9.36 Ki 0.44 Preclinical
CHEMBL5928382 9.28 Ki 0.53 Preclinical
CHEMBL5278003 9.24 Ki 0.58 Preclinical
CHEMBL4647871 9.23 Ki 0.59 Preclinical
CHEMBL5979974 9.17 Ki 0.67 Preclinical
CHEMBL5395523 9.0 Ki 1.0 Preclinical
Distribution

pChEMBL Value Distribution

96
5.0
159
5.5
216
6.0
171
6.5
197
7.0
178
7.5
106
8.0
47
8.5
19
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

LASMIDITAN
CHEMBL3039520
Approved 2020
PITOLISANT HYDROCHLORIDE
CHEMBL4164059
Approved 2016
BREXPIPRAZOLE
CHEMBL2105760
Approved 2015
CARIPRAZINE HYDROCHLORIDE
CHEMBL2024517
Approved 2015
DOLUTEGRAVIR
CHEMBL1229211
Approved 2013
INDACATEROL
CHEMBL1095777
Approved 2009
CINACALCET HYDROCHLORIDE
CHEMBL1200776
Approved 2004
TEGASEROD MALEATE
CHEMBL1516474
Approved 2002
KETOTIFEN FUMARATE
CHEMBL1633
Approved 1999
TOLTERODINE TARTRATE
CHEMBL1722209
Approved 1998
AZELASTINE HYDROCHLORIDE
CHEMBL1200809
Approved 1996
SALMETEROL
CHEMBL1263
Approved 1994
NEFAZODONE HYDROCHLORIDE
CHEMBL1200492
Approved 1994
ASTEMIZOLE
CHEMBL296419
Approved 1988
CLEMASTINE
CHEMBL1626
Approved 1977
LOPERAMIDE HYDROCHLORIDE
CHEMBL1707
Approved 1976
HALOPERIDOL
CHEMBL54
Approved 1967
PROPRANOLOL HYDROCHLORIDE
CHEMBL1671
Approved 1967
HYDROXYCHLOROQUINE
CHEMBL1535
Approved 1955
CHLOROQUINE
CHEMBL76
Approved 1949
Assay Landscape

Assay Landscape

186
Total Assays
839
Tested Compounds
2
Assay Types
Binding — 183 assays, 839 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 147 463 6.6
cell-based format 23 196 7.2
cell membrane format 9 68 6.9
assay format 4 112 7.2
ADME — 3 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 1 5.6

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine